These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subacute endocarditis of an atrial septal closure device in a patient with a patent foramen ovale. Krantz SB; Lawton JS Ann Thorac Surg; 2014 Nov; 98(5):1821-3. PubMed ID: 25441794 [TBL] [Abstract][Full Text] [Related]
3. Cervical spondylodiscitis subsequent to peripherally inserted central catheter-related sepsis: A case report. Leoni MLG; Terranova G J Vasc Access; 2018 May; 19(3):324-327. PubMed ID: 29772985 [No Abstract] [Full Text] [Related]
4. Oral antibiotic treatment of MRSA infections. Cunha BA J Hosp Infect; 2005 May; 60(1):88-90. PubMed ID: 15823667 [No Abstract] [Full Text] [Related]
6. The first case of Staphylococcus aureus ST398 causing bacteremia in an immunocompromised patient in Greece. Drougka E; Foka A; Marangos MN; Liakopoulos A; Makatsoris T; Anastassiou ED; Petinaki E; Spiliopoulou I Indian J Med Microbiol; 2012; 30(2):232-6. PubMed ID: 22664446 [TBL] [Abstract][Full Text] [Related]
7. Health care-associated infections studies project: case 2. Wright MO; Hebden JN; Allen-Bridson K; Morrell GC; Horan T Am J Infect Control; 2010 Sep; 38(7):557-8. PubMed ID: 20619501 [No Abstract] [Full Text] [Related]
8. Amplatzer left atrial appendage occlusion through a patent foramen ovale. Koermendy D; Nietlispach F; Shakir S; Gloekler S; Wenaweser P; Windecker S; Khattab AA; Meier B Catheter Cardiovasc Interv; 2014 Dec; 84(7):1190-6. PubMed ID: 24399612 [TBL] [Abstract][Full Text] [Related]
9. Implantation of a second Amplatzer device to eliminate residual shunt after transcatheter patent foramen ovale closure. Chessa M; Citro R; Butera G; Provenza G; Bossone E; Carminati M J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):736-7. PubMed ID: 19483639 [TBL] [Abstract][Full Text] [Related]
10. Port-related nontyphoidal Salmonella bacteremia. Tang HJ; Chao CM; Lai CC Infect Control Hosp Epidemiol; 2015 Apr; 36(4):492-3. PubMed ID: 25782912 [No Abstract] [Full Text] [Related]
11. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience. Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875 [TBL] [Abstract][Full Text] [Related]
12. Patent foramen ovale: diagnosis with multidetector CT--comparison with transesophageal echocardiography. Kim YJ; Hur J; Shim CY; Lee HJ; Ha JW; Choe KO; Heo JH; Choi EY; Choi BW Radiology; 2009 Jan; 250(1):61-7. PubMed ID: 19001153 [TBL] [Abstract][Full Text] [Related]
17. Cerebral infarction in an HIV-infected patient with combined protein S and C deficiency and a patent foramen ovale. Tomomasa R; Yamashiro K; Tanaka R; Hattori N J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e650-2. PubMed ID: 23664714 [TBL] [Abstract][Full Text] [Related]
18. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985 [TBL] [Abstract][Full Text] [Related]
19. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack. Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of infections in humans due to Staphylococcus epidermidis. Rupp ME Methods Mol Biol; 2014; 1106():1-16. PubMed ID: 24222451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]